Anti-U1 RNP and anti-Sm antibodies;Anticuerpos anti-U1 RNP y anti-Sm

Revista Espanola de Reumatologia

Volumn 23, Issue 9, 1996, Pages 369-374

  López Longo, Francisco Javier ^a   González, Carlos Manuel ^b   Monteagudo, Indalecio ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN ANTIBODY;

HUMAN; MIXED CONNECTIVE TISSUE DISEASE; RAYNAUD PHENOMENON; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030477785     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Tan F.M, Kunkel HG Characteristics of soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus J Immunol 1966. 96- 404-471
2. Sharp GC, Irwin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen Am J Med 1972, 52. 148-159
3. Lerner MR, Steitz JA. Antibodies to small nuclear RXAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979; 76 5 459-5 499
4. Petterson I, Hinterberger M. Mimon T, Gottlieb E, Steitz JA The structure of mammalian small nuclear ribonucleoproteins identification of multiple protein components reactive with ant-(U1 )RNP and anti-Sm antibodies. J Biol Chcm 1984: 259. 5.907-5.914.
5. Rokeach LA, Jannatipour M. Haselbv JA, Hoch SO Mapping of the immunoreactive domains of a small nuclear ribonucleoprotem associated Sm-D autoantigen Clin Immunol Immunopathol 1992-, 65- 315-324.
6. Habets WJ Sillekens PT. Hoet MH. McAllister G, Lerner MR, Van Venrooij WJ Small nuclear RNA associated proteins are immunologically related as revealed by mapping of autoimmune reactive B-cell epitopes. Proc Natl Acad Sei USA 1989. 86: 4.674-4 678.
7. Tan EM Aminuclear antibodies diagnostic markers for autoinmune diseases and probes for cell biology Adv Immunol 1989, 44: 93-151
8. Maddison PJ. Skinner RP, Vlachoyiannopoulos P. Brennand DM, Hough D. Antibodies to nRN7P, Sm. Ro (SSA) and La (SSB) detected by ELISA. their specificity and interrelations in connective tissue diseases sera. Clin Exp Immunol 1985; 62: 337-345.
9. Pettersson I, Wang G, Smith EI et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear nbonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional longitudinal study. Arthritis Rheum 1986, 29: 986-996
10. Van Venrooi WJ, Habets WJ Detection of nuclear antigens recognized by human autoantibodies Scand J Rheumatol 1985, 56 32-41
11. Francoeur AM Analysis of autoantibody specificities in selected systemic lupus ervthematosus sera. J Clin Immunol 1989: 9: 248-255.
12. Pollard KM. Tan EM. Purification of the Sm nuclear autoantigens Detection and clinical significance of antibodies Clin Exp Immunoi 1985: 60: 586-596
13. Tsay G, Chan EKL, Peebles CL, Pollard KM, Tan EM. An immunoassay differentiating sera with antibodies to Sm alone, antibodies to Sm/RNP complex and antibodies to RNP alone Arthritis Rheum 1987, 30: 389-396.
14. Nyman U:. I.undberg I. Hedfors E, Pettersson I. Recombinant 70 KD protein used for determination of autoantigenic epitopes recognized by anti-RNP sera. Clin Exp Immunol 1990; 81 52-58.
15. McHugh N. James I, Maddison P. Clinical significance of antibodies to a 68 KD-U1-RNP polypeptide in connective tissue disorders J Rheumatol 1990; 17: 1.320-1.328.
16. Habets WJ, De Rooij DJ.Hoet MH, Van de Putte LB, Van Venrooij WJ Quantification of anti-RNP and anti-Sm antibodies in mixed connective tissue disease and systemic lupus erythematosus by immunoblotting. Clin Exp Immunoi 1985, 59; 457-466.
17. Barakat S, Briand JP, Abuaf N, Van Regenmortel MHV, Muller S Mapping of epitopes on UlsnRNP polypeptide A with synthetic peptides and autoimmune sera. Clin Exp Immunoi 1991; 86: 71-78.
18. Rokeach LA. Jannatipour M, Hoch SO Heterologous expression and epitope mapping of a human small nuclear nbonucleoprotein-associated Sm BB autoantigen J Immunol 1990; 144. 1.015-1.022.
19. Huntriss ID. Latchman DS. Williams DG Lupus autoantibodies discriminate between the highly homologous Sm polypeptides B B and Sm N by binding an epitope restricte to BB. Clin Exp Immmol 1993; 92: 263-267.
20. Barakat S. Briand JP, Weber JC. Van Regenmortel MHV, Muller S Recognition of synthetic peptides of Sm-D autoantigen by lupus era. Clin Exp Immunol 1990; 81: 256-262
21. James JA. Gross T. Scofield RH Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B -derived PPPGMRPP and PPPG1KGP induce spliceosome autoimmumty. J. Exp Med 1995. 181: 453-461
22. Takeda Y, Wang GS, Wang RJ et al. Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol 1989: 50: 213-220
23. Canuthers CJ. Bell DA Production and characterization of human hybridoma monoclonal anti-Sm and anti-Ul-RNP antibodies spontaneously produced from normal human lymphocytes J Autoimmun 1992; 5 527-544.
24. Bloom DD. Davignon JL. Cohen PL, Eisenberg RA. Clarke SH Overlap of the anti-Sm and anti-DNA responses of MRL Mp-lpr, lpr mice J Immunol 1993; 150 1 579-1.590
25. Zhang W. Reichlin M. IgM anti-A and D snRNP proteins and IgM anti-dsDNA are closely associated in systemic lupus erythematosus sera Clin Immunol Immunopathol 1995; 74 70-76
26. Olsen ML. Arneti FC, Reveille JD. Contrasting molecular patterns of MHC Class II alleles associated with the anti-Sm and anli-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1993; 36 94-104.
27. Kuwana M, Okano Y, Kaburaki J, Tsuji K, Inoko H. Major histocompatibility complex class II gene associations with anti-U1 small nuclear nbonucleoprotein antibody. Relaionship to immunoreactivity with individual constituent proteins Arthritis Rheum 1995; 38: 396-405
28. Hines JJ. Danho W, Elkon KB. Detection and quantification of human anti-Sm antibodies using synthetic peptide and recombinant Sm B antigens. Arthritis Rheum 1991. 34- 572-579.
29. Delpech A. Gilbert D, Daliphard S, Le Loet X, Godm M, Tron F Antibodies to Sm. RNP and SSB detected by solid-phase enzyme-linked immunosorbent assay using recombinant antigens: a comparison study with counterimmunoelectrophoresis and immunoblotting J Clin Lab Anal 1993; 7: 197-202.
30. Abuaf N. Johanet C. Chretien P. Absalon BI. Homberg JC, Buri JF Detection of autoantibodies to Sm antigen by immunodiffusion, ELISA and immunoblotting variability of incidence related to assay and ethnic origin of patients. Eur J Clin Invest 1990, 20. 354-359
31. Reeves WH, Fisher DE. Lahita RG, Kunkel HG Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies. J Clin Invest 1985. 75. 580-587
32. Arnett FC, Hamilton RG, Roebber MG. Harley JB, Reichlin M Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus J Rheumatol 1988; 15: 1.773-1 776
33. Williamson GG. Pennebaker J. Boyle JA. Clinical characteristics of patients with rheumatic disorders who possess antibodies againts RNP particles. Arthritis Rheum 1983. 26: 509-515.
34. Combe B. Ruchcton M. Grafland H, Lussiez V, Bruncl C, Sany J Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 1989, 75: 18-24.
35. Munves EF. Schur PH. Antibodies to Sm and RNP, prognosticators of disease involvement Arthritis Rheum 1983, 26: 848-853.
36. Rasmussen EK,Ullman S. Hoier-Madse M, Sorensen SF, Hallberg P. Clinical implications of RNP antibodies. Arch Dermatol 1987. 123: 601-605
37. Sharp GC, Irvin WS, May CM et al Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976. 295: 1.149-1 154.
38. Kallenherg CG. Ter-Borg EJ, Jaarsma D, Limburg PC. Detection of autoantibodies to ribonucleoproteins by counterimmunoelectrophoresis. immunoblotting and RNA-immunc precipitation: comparison of results. Clin Exp Rheumatol 1990, 8. 35-40
39. Maini RN, Charles PJ, Venables PJW Antinuclear antibodies in the immunotaxonomy of connective tissue diseases Scand J Rheumatol 1985: 56: (Supl) 49-57.
40. Font J, Pallarés L, Cervera R et al Lupus eritematoso sistémico. estudio clínico e inmunológico de 300 pacientes Med Clin 1993, 100: 601-605
41. Clotet B, Guardia J, Pigrau C et al Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis Scand J Rheumatol 1984; 13: 15-20.
42. Juby A, Johnston C, Davis P. Specificity, sensitivity and diagnostic predictive value of selected laboratory generated autoantibody profiles in patients with connective tissue diseases J Rheumatol 1991; 18: 354-358.
43. López-Longo FJ, Fernández J, Monteagudo I et al. Evolución clínica y serológica en pacientes con enfermedad mixta del tejido conectivo. Rev Clin Esp 1994; 194 682-688
44. Reichlin M, Mattioli M. Correlation of a precipitin reaction to RNA-protein antigens and low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 1972; 286 908-911
45. Hirakata H, Mimori T, Akizuki M, Craft J. Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasrmc nbonucleoproteins in Japanese patients with inflammatory muscle disease Arthritis Rheum 1992, 35 449-456.
46. Habets WJ, De Rooij DJ, Salden MH et al. Antibodies against distinct nuclear matrix proteins are characteristics for mixed connective tissue disease Clin Exp Immunol 1983, 54. 265-276.
47. Westgeest AA, Van den Brink HG. De Jong J, Swaak AJ, Smeenk RJ. Routine testing for antmuclear antibodies, a comparison of immunofluorescence, counterimmunoelectrophoresis and immunoblotting. J Autoimmun 1988. 1: 159170.
48. Vencovsky J, Williams DG, Field M, Maini RN. Clinical associations of IgG antibodies to the ribonucleoprotein p67 polypeptide in patients with systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 1 313-1.317
49. Froelich CJ, Wallman J, Skosey JL, Teodorescu M Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA and SSB). J Rheumatol 1990; 17: 192-200.
50. Black C, Isenberg DA Mixed connective tissue disease. Goodbye to all that. Br J Rheumatol 1992; 31. 695-700.
51. Nimelstein SH, Brody S, McShane D, Holman HR Mixed connective tissue disease: a subsequent evaluation of the original 25 patients Medicine 1980; 59: 239-248.
52. De Clerck LS, Merjers KA, Cats A. Is mixed connective tissue disease a distinct entity? Comparison of clinical and laboratory findings in mixed connective tissue disease, systemic lupus erythematosus. progressive systemic sclerosis and rheumatoid arthritis patients Clin Rheumatol 1989; 8: 29-36
53. Van den Hoogen FH, Spronk PE, Boerbooms AM et al. Longtenu follow-up of 46 patients with anti-(Ul) snRNP antibodies. Br J Rheumatol 1994; 33: 1.117-1.120.
54. Vlachoyiannopoulos PG, Guialis A, Tzioufas AG. Moutsopoulos HM. Predominance of IgM anti-UlRNP antibodies in patients with systemic lupus erythematosus. Br J Rheumatol 1996; 35: 534-541.
55. Kurata N, Tan EM. Identification of antibodies to nuclear acidic antigen by counterimmunoelectrophoresis. Arthritis Rheum 1976, 19: 574-578.
56. Notman DD. Kurata N, Tan EM. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 1975, 83: 464-469.
57. Argov S, Jaffe CL, Krupp M, Slor H, Shoenfeld Y Autoantibody production by patients infected with leishmania. Clin Exp Immunol 1989, 76: 190-197.
58. Rodigucz-Mahou M, López-Longo FJ. Lapointe N et al Autoimmune phenomena in children with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Acta Pediatr Scand 1994. 400: (SupD 31-34.
59. Swissa M, Cohen Y, Shoenfeld Y Autoantibodies in the sera of patients with lymphoma Leuk Lymphoma 1992, 7 117-122.
60. Lundberg I, Nyman U, Pettersson I, Hedforr F Clinical manifestations and anti-(U1) snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients Br J Rheumatol 1992; 31: 811-817.
61. 6l Ter Borg EJ. Groen H, Horts G, Limburg PC, Wouda AA, Kallenberg CGM Clinical associations of antinbonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20: 164-173
62. Peǹa JL, Riestra JL, Sánchez S, González-Gay MA, Gómez Reino J, Sampedro J. Significado clínico, analítico e histológico renal de los anticuerpos contra ENA en pacientes con LES. Rev Esp Reumatol 1984, 11: 70-73.
63. Rodríguez M, Mulero J, Caspar ML, Noguera E. Marenco JL, Gutiérrez C. Manifestaciones clínicas en pacientes con lupus eritematoso sistémico portadores de anticuerpos anti-ENA Rev Esp Reumatol 1985, 12: 6-9
64. Westgeest AA. Van Den Brink HG, De Jong J, Swaak AJ, Smeenk RJ Antinuclear antibodies in patients with systemic lupus erythematosus, A comparison of counterimmunoelectrophoresis and immunoblotting. Rheumatol Int 1987; 27: 7782.
65. Bernstein RM, Bunn CC. Hughes GRV, Francoeur AM, Mathews MB. Cellular proteins and RNA antigens in autoimmune diseases. Mol Biol Med 1984, 2 105-120
66. Field M, Williams DG. Charles P, Maini RN Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detections using purified peptide antigens Ann Rheum Dis 1988, 47: 820-825
67. Winn DM, Wolfe JF, Lmdberg DA, Fristoe FH, Kingsland L, Sharp GC Identification of a clinical subset of systemic lupus erythematosus by antibodies to Sm antigen. Arthritis Rheum 1977; 22 1.334-1.337.
68. Barada FA, Andrews BS, Davis JS, Taylor RP Antibodies to Sm in patients with systemic lupus erythematosus Correlation of Sm antibodies titers with disease activity and other laboratory parameters Arthritis Rheum 1981; 24: 1236-1244
69. Yasuma M, Takasaki Y, Matsumoto K, Kosama A, Hashimoto H, Hirose SI. Clinical significance of IgG-anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 1990, 17: 469-475.
70. Dorsch CA, Feinglass EJ, Stevens MB. Clinical significance of antibodies to ENA in systemic lupus erythematosus. Arthritis Rheum 1977. 20 114-118.
71. López-Longo FJ. Rodríguez-Mahou M. González CM et al Anti-BB'-Sm antibodies, anticardiolipin and thrombotic events in systemic lupus erythematosus [resumen] Arthritis Rheum 1993- 36 (9): 124.
72. Kurata N, Hara I. Kinashi M, Akita H, Ofujn T. The correlation of antibodies to nRNP and nuclear acidic protein (Sm) with nephritis in patients with systemic lupus erythematosus. Contnb Nephrol 1978; 9: 17-24
73. Le Feber WP, Norris DA, Ryan SR et al Ultraviolet light induces expression of selected nuclear antigens of cultured human keratinocytes J Clin Invest 1984; 74: 1 545-1.551.
74. Norris DA, Lee LA Antibody-dependent cellular toxicity and skin disease. J Invest Dermatol 1985; 85: 165-175.
75. AIarcón-Segovia D, Ruiz-Argüelles A, Fishbein E. Antibody to nbonucleoprotein penetrates live human mononuclear cells through Fc receptors Nature (Lond) 1979, 271: 67-69